story of the week
Efficacy of Treatment With an Oral IL-23 Receptor Antagonist Peptide in Patients With Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis
N. Engl. J. Med 2024 Feb 08;390(6)510-521, R Bissonnette, A Pinter, LK Ferris, S Gerdes, P Rich, R Vender, M Miller, YK Shen, A Kannan, S Li, C DeKlotz, K PappFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.